NCT01833533View on ClinicalTrials.gov

A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection

PHASE3CompletedINTERVENTIONAL

Enrollment

305

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

September 30, 2014

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG

ABT-450/r/ABT-267, ABT-333

Tablet; ABT-450 coformulated with ritonavir and ABT-267, ABT-333 tablet

DRUG

Ribavirin

Capsule

DRUG

Placebo for Ribavirin

Capsule

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY